SEC Form 4 · accession 0001162194-17-000088
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel D Colella
Director
Period of report
Jul 31, 2017
Accepted (ET)
Aug 2, 2017 · 8:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2017 | M | 5,000 | $0.00 | A | 45,197 | D | |
| Common StockF1 | holding | — | — | — | 5,561 | I | Colella Family Partners, L.P | |
| Common Stock | holding | — | — | — | 17,500 | I | Colella Family Exempt Marital Deduction Trust dated 9/21/1992 | |
| Common Stock | holding | — | — | — | 3,326 | I | Colella Family Non-Exempt Marital Deduction Trust dated 9/21/1992 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | — | Jul 31, 2017 | M | 5,000 | D | Jul 31, 2017 | Jul 31, 2017 | Common Stock | 5,000 | 0 | D |
| Restricted Stock UnitsF2,F3 | — | Aug 1, 2017 | A | 5,000 | A | — | — | Common Stock | 5,000 | 5,000 | D |
| Stock Option (Right to Buy)F4 | $3.43 | Aug 1, 2017 | A | 5,000 | A | — | Aug 1, 2027 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions by Versant Ventures I, LLC, which is the general partner of each of Versant Venture Capital I, L.P., Versant Side Fund I, L.P., Versant Affiliates Fund I-A, L.P. and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"), on November 4, 2013. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.
- F2Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F3All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director through the vesting date.
- F41/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on August 1, 2018.